Literature DB >> 27829642

Reversible Motor Paralysis and Early Cardiac Rehabilitation in Patients With Advanced Heart Failure Receiving Left Ventricular Assist Device Therapy.

Rie Amao1, Teruhiko Imamura, Yasuo Nakahara, Satoko Noguchi, Osamu Kinoshita, Haruo Yamauchi, Minoru Ono, Nobuhiko Haga.   

Abstract

Advanced heart failure (HF) is sometimes complicated with brain impairment because of a microthrombosis caused by decreased left ventricular contraction or reduced brain circulation. Some patients may recover after left ventricular assist device (LVAD) implantation. However, little is known about the perioperative therapeutic strategy in patients suffering from such complications, particularly from a cardiac rehabilitation viewpoint. We report on a 58-year-old male patient with a previous history of poliomyelitis and a light paralysis in the left upper extremity, who suffered left hemiplegia with no evidence of stroke after hemodynamic deterioration. The combination therapy of perioperative cardiac rehabilitation and LVAD therapy improved his left hemiplegia as well as activities of daily living, and the patient was discharged on foot on postoperative day 72 after briefing the family on LVAD home management. Early initiation of cardiac rehabilitation before LVAD implantation may be a key for the smooth discharge and resocialization of patients suffering from brain impairment complicated with advanced HF.

Entities:  

Mesh:

Year:  2016        PMID: 27829642     DOI: 10.1536/ihj.16-153

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  2 in total

1.  Effect of Cardiac Rehabilitation Therapy Combined with WeChat Platform Education on Patients with Unstable Angina Pectoris after PCI.

Authors:  Bin Wang; Yanling Hong; Yibin Gao; Mao Tian; Qiang Lin; Jiawei Wang; Yu Wang; Xiang Li
Journal:  J Healthc Eng       Date:  2022-03-07       Impact factor: 2.682

2.  Effect of vitamin D on ventricular remodelling in heart failure: a meta-analysis of randomised controlled trials.

Authors:  Jin-Dong Zhao; Jing-Jing Jia; Ping-Shuan Dong; Di Zhao; Xu-Ming Yang; Dao-Lin Li; Hui-Feng Zhang
Journal:  BMJ Open       Date:  2018-08-30       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.